The role of complement in cancer is complex and is dependent on the type of cancer. However, most data indicates that, if the complement system is highly engaged, it has a strong antitumour effect.

UK start-up Complement Therapeutics has raised an impressive €72 million ($79 million) in first-round financing that will be used to take a gene therapy for sight-robbing disease geographic ...